French biotech firm Acticor Biotech fetches funding
Paris-based Acticor Biotech, a biotech company involved in the acute phase of thrombotic diseases, has raised 1.7 million euros in funding. Primer Capital led the round.
4 January 2018•1 min read
Paris-based Acticor Biotech, a biotech company involved in the acute phase of thrombotic diseases, has raised 1.7 million euros in funding. Primer Capital led the round.
